-
Product Insights
NewToku Eyes Ltd Pipeline Insight and Competitive Landscape, 2023
Empower your strategies with our Toku Eyes Ltd Pipeline Insight and Competitive Landscape, 2023 report and make more profitable business decisions. Toku Eyes Ltd (Toku Eyes) provides screening, diagnosis & prognosis for cardiovascular & ocular diseases. Toku Eyes is headquartered in Auckland, New Zealand. GlobalData's Medical Devices company profile report, “Toku Eyes Ltd Pipeline Insight and Competitive Landscape, 2023" provides information about the company overview and analysis on their pipeline products. This company profile report provides key information and data...
-
Product Insights
NewLikelihood of Approval and Phase Transition Success Rate Model – Pilocarpine in Keratoconjunctivitis Sicca (Dry Eye)
Empower your strategies with our Likelihood of Approval and Phase Transition Success Rate Model - Pilocarpine in Keratoconjunctivitis Sicca (Dry Eye) report and make more profitable business decisions. This report provides you with the data that allows you to track and predict the specific likelihood of approval (LOA) and phase transition success rate (PTSR) of a drug using GlobalData’s proprietary machine learning algorithms developed using over 10 years of historical data. Pilocarpine in Keratoconjunctivitis Sicca (Dry Eye) Drug Details: Pilocarpine is...
-
Product Insights
NewLikelihood of Approval and Phase Transition Success Rate Model – EYE-103 in Diabetic Macular Edema
Empower your strategies with our Likelihood of Approval and Phase Transition Success Rate Model - EYE-103 in Diabetic Macular Edema report and make more profitable business decisions. This report provides you with the data that allows you to track and predict the specific likelihood of approval (LOA) and phase transition success rate (PTSR) of a drug using GlobalData’s proprietary machine learning algorithms developed using over 10 years of historical data. EYE-103 in Diabetic Macular Edema Drug Details: EYE-103 is under development...
-
Product Insights
NewLikelihood of Approval and Phase Transition Success Rate Model – Dexamethasone Acetate in Ocular Pain (Eye Pain)
Empower your strategies with our Likelihood of Approval and Phase Transition Success Rate Model - Dexamethasone Acetate in Ocular Pain (Eye Pain) report and make more profitable business decisions. This report provides you with the data that allows you to track and predict the specific likelihood of approval (LOA) and phase transition success rate (PTSR) of a drug using GlobalData’s proprietary machine learning algorithms developed using over 10 years of historical data. Dexamethasone Acetate in Ocular Pain (Eye Pain) Drug...
-
Product Insights
NewLikelihood of Approval and Phase Transition Success Rate Model – AVI-4015 in Keratoconjunctivitis Sicca (Dry Eye)
Empower your strategies with our Likelihood of Approval and Phase Transition Success Rate Model - AVI-4015 in Keratoconjunctivitis Sicca (Dry Eye) report and make more profitable business decisions. This report provides you with the data that allows you to track and predict the specific likelihood of approval (LOA) and phase transition success rate (PTSR) of a drug using GlobalData’s proprietary machine learning algorithms developed using over 10 years of historical data. AVI-4015 in Keratoconjunctivitis Sicca (Dry Eye) Drug Details: AVI-4015...
-
Product Insights
NewLikelihood of Approval and Phase Transition Success Rate Model – VVN-001 in Keratoconjunctivitis Sicca (Dry Eye)
Empower your strategies with our Likelihood of Approval and Phase Transition Success Rate Model - VVN-001 in Keratoconjunctivitis Sicca (Dry Eye) report and make more profitable business decisions. This report provides you with the data that allows you to track and predict the specific likelihood of approval (LOA) and phase transition success rate (PTSR) of a drug using GlobalData’s proprietary machine learning algorithms developed using over 10 years of historical data. VVN-001 in Keratoconjunctivitis Sicca (Dry Eye) Drug Details: VVN-001...
-
Product Insights
NewLikelihood of Approval and Phase Transition Success Rate Model – PL-9643 in Keratoconjunctivitis Sicca (Dry Eye)
Empower your strategies with our Likelihood of Approval and Phase Transition Success Rate Model - PL-9643 in Keratoconjunctivitis Sicca (Dry Eye) report and make more profitable business decisions. This report provides you with the data that allows you to track and predict the specific likelihood of approval (LOA) and phase transition success rate (PTSR) of a drug using GlobalData’s proprietary machine learning algorithms developed using over 10 years of historical data. PL-9643 in Keratoconjunctivitis Sicca (Dry Eye) Drug Details: PL-9643...
-
Product Insights
NewLikelihood of Approval and Phase Transition Success Rate Model – Selenium Sulfide in Keratoconjunctivitis Sicca (Dry Eye)
Empower your strategies with our Likelihood of Approval and Phase Transition Success Rate Model - Selenium Sulfide in Keratoconjunctivitis Sicca (Dry Eye) report and make more profitable business decisions. This report provides you with the data that allows you to track and predict the specific likelihood of approval (LOA) and phase transition success rate (PTSR) of a drug using GlobalData’s proprietary machine learning algorithms developed using over 10 years of historical data. Selenium Sulfide in Keratoconjunctivitis Sicca (Dry Eye) Drug...
-
Product Insights
NewLikelihood of Approval and Phase Transition Success Rate Model – VSJ-110 in Keratoconjunctivitis Sicca (Dry Eye)
Empower your strategies with our Likelihood of Approval and Phase Transition Success Rate Model - VSJ-110 in Keratoconjunctivitis Sicca (Dry Eye) report and make more profitable business decisions. This report provides you with the data that allows you to track and predict the specific likelihood of approval (LOA) and phase transition success rate (PTSR) of a drug using GlobalData’s proprietary machine learning algorithms developed using over 10 years of historical data. VSJ-110 in Keratoconjunctivitis Sicca (Dry Eye) Drug Details: VSJ-110...